Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020

By afschroeder • March 7, 2026

Donohue J, Wang B, Tang L, Kim JY, Junker S, Cole E, Chang CH, Roberts E, Wilson JD, Essien U, Gifford K, Hammerslag L, Talbert J, Ahrens K, Idala D, Mohamoud S, Clark S, Austin A, Ware O, Tossone K, Mack A, Fry C, Gordon AJ, Barnes A, Marks S, Cunningham P, Allen L, Burns M, Kennedy S. Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020. J Subst Use Addict Treat. 2026 Mar 4:209924. doi: 10.1016/j.josat.2026.209924. Epub ahead of print. PMID: 41791553.

Tags: buprenorphine, General Internal Medicine, medicaid, Medication for opioid-use disorder, methadone, naltrexone, Overdose, Publications, Racial/ethnic differences, Veterans Administration

Pager

Choo S. Pager. JAMA. 2026 Jun 17. doi: 10.1001/jama.2026.6134. Epub ahead of print. PMID: 42307957.

A is for ___ : Narrative Medicine Framework for Mental Health Empowerment and Self-Authorship in Asian American Communities

Yan MJ, Lee HJ, Yan AJ, Yan VC, Bahk JE, Chen JA, Trinh NT, Ng WYK, Lu FG. A is for _ : Narrative Medicine[...]

Update on Diet and Nutritional Therapies in Patients with Inflammatory Bowel Disease

Baniqued MR, Shah ND, Dominguez J, Parian AM. Update on Diet and Nutritional Therapies in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2026 Jun[...]